公司資料
BioLife Solutions 股價、新聞與催化劑
- 股票代碼:
- BLFS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
36.78 USD (-5.33%)
收盤價
最後更新: 2026年10月1日
1.34B USD
市值
股價為何變動
截至 2026年10月1日，BLFS 下跌 5.33%，收於 $36.78。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Cell and Gene Therapy Tools Supplier
BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market.
Biopreservation Media
CryoStor and HypoThermosol media are designed to preserve cells and tissues during freezing, storage, shipping, and clinical handling. These products are incorporated into a large number of clinical trials and approved cell and gene therapies.
Cell-Processing Consumables
The portfolio includes CellSeal cryogenic vials, human platelet lysate products, and other materials used in cell manufacturing. These products support closed or controlled workflows as therapies move from research into regulated production.
Embedded Clinical-to-Commercial Model
Once a BioLife product is written into a therapy's manufacturing process, changing suppliers can require technical and regulatory work. This creates recurring demand as customer programs advance from clinical trials to commercial treatment volumes.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。